These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [HIF-ɑ: New Target For Treatment of Renal Anemia. Molecular Aspects and Activation of Pathway HREs].
    Author: Mazza F, Cicciarelli A, Rubino F, Apponi F, Cioffi EA, Simonelli R.
    Journal: G Ital Nefrol; 2024 Jun 28; 41(3):. PubMed ID: 38943324.
    Abstract:
    Roxadustat, recently approved, is a hypoxia-inducible factor prolyl hydroxylase inhibitor that has demonstrated favorable safety and efficacy in the treatment of renal anemia. This article reviews main features and possible effects by activation of pathway sequences HREs.
    [Abstract] [Full Text] [Related] [New Search]